Leukotech A/S is a biopharmaceutical start-up company that researches and develops agents to prevent and treat life-threatening infections and severe inflammatory disorders. The company focuses on gene technology, mammalian cell culture, protein purification and characterization, analytical chemistry, and immunochemistry. The company is based in Copenhagen, Denmark.